Mark R Bamforth's Net Worth

$3.02 Million

Estimate Recalculated Nov 1, 2024 08:41AM EST

Who is Mark R Bamforth

Mark R Bamforth has an estimated net worth of $3.02 Million. This is based on reported shares across multiple companies, which include GENZYME CORP, and PEREGRINE PHARMACEUTICALS INC.

SEC CIK

Mark R Bamforth's CIK is 0001435745

Past Insider Trading and Trends

2017 was Mark R Bamforth's most active year for acquiring shares with 9 total transactions. Mark R Bamforth's most active month to acquire stocks was the month of September. 2008 was Mark R Bamforth's most active year for disposing of shares, totalling 6 transactions. Mark R Bamforth's most active month to dispose stocks was the month of July. 2008 saw Mark R Bamforth paying a total of $1,472,982.20 for 65,012 shares, this is the most they've acquired in one year. In 2021 Mark R Bamforth cashed out on 100,000 shares for a total of $1,818,000.00, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

GENZYME CORP

Sr.VP, Corp. Operations & Phar
Updated May 26, 2009
19.00KMay 21
Mar 04
Aug 14
Aug 06
Form 4/A6.45KScheduledJul 15
ScheduledJul 15
20.00KMay 22
3.66K
Showing 8 results

PEREGRINE PHARMACEUTICALS INC

Investor
Updated Mar 19, 2021
Mar 17
126.68KDec 14
Mar 13
114.28KJan 09
94.60KDec 14
Feb 15
Oct 27
75.00KOct 17
Showing 9 results